XYL
29
4
CF
47
5
EQR
33
6
STX
34
2
ORLY
48
3
CINF
24
-8
CRM
65
6
XEL
48
11
PHM
44
4
TXN
29
4
HST
53
4
VNO
46
6
AEE
51
3
SLG
37
6
EXPE
83
8
JPM
59
6
TMO
52
8
KHC
11
2
GE
60
5
VRSN
59
4
XYL
29
4
CF
47
5
EQR
33
6
STX
34
2
ORLY
48
3
CINF
24
-8
CRM
65
6
XEL
48
11
PHM
44
4
TXN
29
4
HST
53
4
VNO
46
6
AEE
51
3
SLG
37
6
EXPE
83
8
JPM
59
6
TMO
52
8
KHC
11
2
GE
60
5
VRSN
59
4
Financhill
Back

Kimbell Royalty Partners LP Vs. Novo Nordisk AS Industry Stock Comparison

Sell
48

KRP
Kimbell Royalty Partners LP

Last Price:
$15.43
Seasonality Move:
-2.12%
Sell
13

NONOF
Novo Nordisk AS

Last Price:
$84.75
Seasonality Move:
6.94%
Sell
48
Kimbell Royalty Partners LP (KRP) is a Sell

Is Kimbell Royalty Partners LP a Buy, Sell or Hold?

  • The current Kimbell Royalty Partners LP [KRP] share price is $15.41. The Score for KRP is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • KRP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
13
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $84.75. The Score for NONOF is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

KRP Stock Price Chart

What is Kimbell Royalty Partners LP's stock price today?

  • The Kimbell Royalty Partners LP share price today is $15.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KRP is experiencing slight buying pressure.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $84.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.

KRP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 34.77 Sell
Chaikin Money Flow: 66004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.63 - 16.07) Sell
Bollinger Bands (100): (15.6 - 16.26) Sell

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.51 Sell
Relative Strength Index (14 RSI): 24.55 Sell
Chaikin Money Flow: 64911 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.57 - 111.43) Sell
Bollinger Bands (100): (107.18 - 131.16) Sell

KRP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.63 Sell
20-day SMA: 15.82 Sell
50-day SMA: 16.03 Sell
200-day SMA: 16.09 Sell
8-day EMA: 15.58 Sell
20-day EMA: 15.77 Sell
50-day EMA: 15.93 Sell
200-day EMA: 15.97 Sell

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 105.03 Sell
20-day SMA: 106.85 Sell
50-day SMA: 109.33 Sell
200-day SMA: 126.14 Sell
8-day EMA: 102.09 Sell
20-day EMA: 105.65 Sell
50-day EMA: 110.06 Sell
200-day EMA: 118.01 Sell

Kimbell Royalty Partners LP Earnings Growth & KRP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and an increase next year of $0.34 per share.

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Kimbell Royalty Partners LP Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):